Axcelead
Fujisawa, Japan
Axcelead DDP is Japan’s first drug discovery solution provider, established in July 2017 by inheriting the drug discovery platform from Takeda Pharmaceutical. Screening, medicinal chemistry, pharmacology/biology, DMPK, and safety research functions are integrated into one center with a state-of-the-art research base and original compound library. With the most advanced AI capability integration to Axcelead DDP’s service, Axcelead DDP can rapidly create high-quality drug candidates. By leveraging these strengths, Axcelead DDP provides solutions to various challenges faced across drug discovery.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- axcelead-us.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Axcelead?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now